Soigner l’alcoolisme et la dépression avec des psychédéliques? Entretien avec David Nutt

#RTSsanté , 11 avril 2019

Vidéo en complément du reportage « Le retour des psychédéliques » : https://youtu.be/503cSLA0Z38

 

Parmi les très nombreux articles cosignés par le Professeur David J. NUTT, du Psychedelic Research Group, Department of Medicine, Imperial College London, London, United Kingdom, les références suivantes sont disponibles sur le site du GRECC :

 

Dissociable effects of cannabis with and without cannabidiol on the human brain’s resting-state functional connectivity,

Matthew B. Wall, Rebecca Pope, Tom P. Freeman, Oliwia S. Kowalczyk, Lysia Demetriou, Claire Mokrysz, Chandni Hindocha, Will Lawn, Michael A.P. Bloomfield, Abigail M. Freeman, Amanda Feilding, David J. Nutt and H. Valerie Curran, Journal of Psychopharmacology, 2019, 1–9.

https://doi.org/10.1177/0269881119841568

 

Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives,

Carla Pallavicini, Martina G. Vilas, Mirta Villarreal, Federico Zamberlan, Suresh Muthukumaraswamy, David Nutt, Robin Carhart-Harris, Enzo Tagliazucchi, NeuroImage, 2019.

https://doi.org/10.1016/j.neuroimage.2019.06.053

 

Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin,

Louis-David Lord, Paul Expert, Selen Atasoy, Leor Roseman, Kristina Rapuano, Renaud Lambiotte, David J. Nutt, Gustavo Deco, Robin L. Carhart-Harris, Morten L. Kringelbach, Joana Cabral, NeuroImage, 2019, 199, 127–142.

https://doi.org/10.1016/j.neuroimage.2019.05.060

 

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy,

Ben Sessa, Laurie Higbed and David Nutt, Frontiers in Psychiatry, 2019, Vol. 10, article 138.

https://doi.org/10.3389/fpsyt.2019.00138

 

Microdosing psychedelics: More questions than answers? An overview and suggestions for future research,

Kim P.C. Kuypers, Livia Ng, David Erritzoe, Gitte M. Knudsen, Charles D. Nichols, David E. Nichols, Luca Pani, Anaïs Soula and David Nutt, Journal of Psychopharmacology, 2019, 1-10.

https://doi.org/10.1177/0269881119857204

 

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression,

Leor Roseman, David J. Nutt, Robin L. Carhart-Harris, Frontiers in Pharmacology, 2018, 8, article 974.

https://doi.org/10.3389/fphar.2017.00974

 

Effects of psilocybin therapy on personnality structure,

ERRITZOE D., ROSEMAN L., NOUR M.M., MacLEAN K., KAELEN M., NUTT D.J., CARHART-HARRIS R.L., Acta Psychiatrica Scandinavica, 2018, 1-11.

https://doi.org/10.1111/acps.12904

 

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression,

Leor Roseman, Lysia Demetriou, Matthew B. Wall, David J. Nutt, Robin L. Carhart-Harris, Neuropharmacology, 2018, 142, 263e269.

https://doi.org/10.1016/j.neuropharm.2017.12.041

 

Psychiatry & the psychedelic drugs. Past, present & future,

James J.H. Rucker, Jonathan Iliff, David J. Nutt, Neuropharmacology, 2018, 142, 200e218

https://doi.org/10.1016/j.neuropharm.2017.12.040

 

Predicting Responses to Psychedelics : A Prospective Study,

Eline C. H. M. Haijen, Mendel Kaelen, Leor Roseman, Christopher Timmermann, Hannes Kettner, Suzanne Russ, David Nutt, Richard E. Daws, Adam D. G. Hampshire, Romy Lorenz  and Robin L. Carhart-Harris, Frontiers in Pharmacology, 2018, 9, Article 897.

https://doi.org/10.3389/fphar.2018.00897

 

Psilocybin with psychological support for treatment resistant depression : six-month follow-up,

L. Carhart-Harris, M. Bolstridge, C. M. J. Day, J. Rucker, R. Watts, D. E. Erritzoe,  M. Kaelen,  B. Giribaldi, M. Bloomfield, S. Pilling, J. A. Rickard, B. Forbes,  A. Feilding,  D. Taylor, H. V. Curran, D. J. Nutt, Psychopharmacology, 2017.

https://doi.org/10.1007/s00213-017-4771-x 

 

The paradoxical psychological effects of lysergic acid diethylamide (LSD)

L. Carhart-Harris, M. Kaelen, M. Bolstridge, T. M. Williams, L. T. Williams, R. Underwood, A. Feilding and D. J. Nutt, Psychological Medicine, 2016, 46, 1379–1390.

https://doi.org/10.1017/S0033291715002901

 

Neural correlates of the LSD experience revealed by multimodal neuro-imagerie

Robin L. Carhart-Harris, Suresh Muthukumaraswamy, Leor Roseman, Mendel Kaelen, Wouter Droog, Kevin Murphy, Enzo Tagliazucchi, Eduardo E. Schenberg, Timothy Nest, Csaba Orban, Robert Leech, Luke T. Williams, Tim M. Williams, Mark Bolstridge, Ben Sessa, John McGonigle, Martin I. Sereno, David Nichols, Peter J. Hellyer, Peter Hobden, John Evans, Krish D. Singh, Richard G. Wise, H. Valerie Curran, Amanda Feilding, and David J. Nutt, PNAS (Proceedings of The National Academy of Sciences of the USA), 2016, 113, 17, 4853-4858.

www.pnas.org/cgi/doi/10.1073/pnas.1518377113

 

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity

Robin L. Carhart-Harris, Kevin Murphy, Robert Leech, David Erritzoe, Matthew B. Wall, Bart Ferguson, Luke T.J. Williams, Leor Roseman, Stefan Brugger, Ineke De Meer, Mark Tanner, Robin Tyacke, Kim Wolff, Ajun Sethi, Michael A.P. Bloomfield, Tim M. Williams, Mark Bolstridge, Lorna Stewart, Celia Morgan, Rexford D. Newbould, Amanda Feilding, H. Val Curran, and David J. Nutt, Biological Psychiatry, 2015, 78, 554-562.

http://dx.doi.org/10.1016/j.biopsych.2013.12.015

 

LSD enhances suggestibility in healthy volunteers,

L. Carhart-Harris, M. Kaelen, M. G. Whalley, M. Bolstridge, A. Feilding, D. J. Nutt, Psychopharmacology, 2014.

https://doi.org/10.1007/s00213-014-3714-z

 

Homological scaffolds of brain functional networks

G. Petri, Paul Expert, F. Turkheimer, Robin Carhart-Harris, David Nutt, P.J. Hellyer, F. Vaccarino, Journal of The Royal Society, Interface, 2014, 11, 20140873

https://doi.org/10.1098/rsif.2014.0873

 

How do hallucinogens work on the brain ?,

Robin Carhart-Harris, Mendel Kaelen and David Nutt, The Psychologist, 2014, 27, 9, 662-665.

 

Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis

Robin L. Carhart-Harris, Robert Leech, David Erritzoe, Tim M. Williams, James M. Stone, John Evans, David J. Sharp, Amanda Feilding, Richard G. Wise, and David J. Nutt, Schizophrenia Bulletin, 2013, 39, (6), 1343–1351.

https://doi.org/10.1093/schbul/sbs117

 

Effects of Schedule I drug laws on neuroscience research and treatment innovation,

Nutt D.J., King L.A., Nichols D.E., Nature Reviews Neuroscience, 2013, 14, 577-585

https://doi.org/10.1038/nrn3530

 

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybine

Robin L. Carhart-Harris, David Erritzoe, Tim Williams, James M. Stone, Laurence J. Reed, Alessandro Colasanti, Robin J. Tyacke, Robert Leech, Andrea L. Malizia, Kevin Murphy, Peter Hobden, John Evans, Amanda Feilding, Richard G. Wise, and David J. Nutt, PNAS, Proceedings of the National Academy of Sciences of the USA, 2012, 109, (6), 2138-2143.

https://doi.org/10.1073/pnas.1119598109

 

Implications for psychedelic-assisted psychotherapy : a functional magnetic resonance imaging study with psilocybin

L. Carhart-Harris, R. Leech, T. M. Williams, D. Erritzoe, N. Abbasi, T. Bargiotas, P. Hobden, D. J. Sharp, J. Evans, A. Feilding, R. G. Wise and D. J. Nutt, British Journal of Psychiatry, 2012, 200, 238-244.

https://doi.org/10.1192/bjp.bp.111.103309

 

Bibliographie David J. Nutt et coll.